Dr. Adam Perlman, Former Medical Director at Mayo Clinic, Joins Pendulum Therapeutics as Chief Medical Officer
- Today, Pendulum Therapeutics , the leading microbiome biotech company pioneering the next frontier of metabolic health, announced that former Mayo Clinic Medical Director and Executive Director for Integrative Medicine at Duke University, Adam Perlman, MD, MPH, FACP, has joined the company as Chief Medical Officer.
- - Today, Pendulum Therapeutics , the leading microbiome biotech company pioneering the next frontier of metabolic health, announced that former Mayo Clinic Medical Director and Executive Director for Integrative Medicine at Duke University, Adam Perlman, MD, MPH, FACP, has joined the company as Chief Medical Officer.
- View the full release here: https://www.businesswire.com/news/home/20240109713201/en/
Dr. Perlman, Chief Medical Officer at Pendulum Therapeutics (Photo: Pendulum Therapeutics)
As Chief Medical Officer at Pendulum, he will oversee the company’s clinical research portfolio, working internally and with academic collaborators to uncover new insights and inform the development of new products that will deliver strong clinical efficacy and outcomes for consumers. - Dr. Perlman saw first hand the efficacy of Pendulum probiotics in his practice, observing benefits in his patients with pre-diabetes and type 2 diabetes.
- Berry joined Pendulum’s all-star lineup of investors, including Sequoia Capital, Meritech Capital, True Ventures, Khosla Ventures and the Mayo Clinic.